Structure

Physi-Chem Properties

Molecular Weight:  550.29
Volume:  576.982
LogP:  4.656
LogD:  3.976
LogS:  -5.208
# Rotatable Bonds:  7
TPSA:  99.88
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.416
Synthetic Accessibility Score:  5.336
Fsp3:  0.636
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.321
MDCK Permeability:  2.8709142497973517e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  0.941

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.089
Plasma Protein Binding (PPB):  90.90056610107422%
Volume Distribution (VD):  2.051
Pgp-substrate:  9.97762680053711%

ADMET: Metabolism

CYP1A2-inhibitor:  0.007
CYP1A2-substrate:  0.121
CYP2C19-inhibitor:  0.167
CYP2C19-substrate:  0.838
CYP2C9-inhibitor:  0.719
CYP2C9-substrate:  0.034
CYP2D6-inhibitor:  0.081
CYP2D6-substrate:  0.017
CYP3A4-inhibitor:  0.886
CYP3A4-substrate:  0.914

ADMET: Excretion

Clearance (CL):  7.635
Half-life (T1/2):  0.121

ADMET: Toxicity

hERG Blockers:  0.232
Human Hepatotoxicity (H-HT):  0.335
Drug-inuced Liver Injury (DILI):  0.271
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.5
Maximum Recommended Daily Dose:  0.924
Skin Sensitization:  0.146
Carcinogencity:  0.184
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.981

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471292

Natural Product ID:  NPC471292
Common Name*:   Rel-Cochinchinoid H
IUPAC Name:   [(5R,7R,8R,9R,10S,11S,13S,17R)-11-acetyloxy-17-(furan-3-yl)-4,4,8,10,13-pentamethyl-3,16-dioxo-6,7,9,11,12,17-hexahydro-5H-cyclopenta[a]phenanthren-7-yl] 2-methylbutanoate
Synonyms:  
Standard InCHIKey:  IELZXMUWBMNRHA-HKYCMNFESA-N
Standard InCHI:  InChI=1S/C33H42O7/c1-9-18(2)29(37)40-26-15-23-30(4,5)25(36)10-12-31(23,6)28-22(39-19(3)34)16-32(7)24(33(26,28)8)14-21(35)27(32)20-11-13-38-17-20/h10-14,17-18,22-23,26-28H,9,15-16H2,1-8H3/t18?,22-,23-,26+,27+,28+,31-,32+,33+/m0/s1
SMILES:  CCC(C(=O)O[C@@H]1C[C@@H]2[C@]([C@@H]3[C@]1(C)C1=CC(=O)[C@H]([C@@]1(C[C@@H]3OC(=O)C)C)c1ccoc1)(C)C=CC(=O)C2(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409063
PubChem CID:   71745145
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8774 Walsura cochinchinensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[23795939]
NPO8774 Walsura cochinchinensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1137 Individual Protein 11-beta-hydroxysteroid dehydrogenase 1 Homo sapiens IC50 = 11400.0 nM PMID[527149]
NPT1137 Individual Protein 11-beta-hydroxysteroid dehydrogenase 1 Homo sapiens Inhibition > 50.0 % PMID[527149]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471292 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9855 High Similarity NPC238843
0.9855 High Similarity NPC199044
0.9565 High Similarity NPC56197
0.9379 High Similarity NPC272590
0.9366 High Similarity NPC185456
0.932 High Similarity NPC25351
0.9189 High Similarity NPC92979
0.9178 High Similarity NPC470997
0.911 High Similarity NPC234494
0.911 High Similarity NPC471001
0.9103 High Similarity NPC302987
0.9103 High Similarity NPC471174
0.9067 High Similarity NPC469847
0.9054 High Similarity NPC33938
0.8986 High Similarity NPC116717
0.8973 High Similarity NPC216755
0.8954 High Similarity NPC663
0.8954 High Similarity NPC224394
0.8926 High Similarity NPC246164
0.8919 High Similarity NPC469335
0.8919 High Similarity NPC156189
0.8919 High Similarity NPC159927
0.8904 High Similarity NPC470999
0.8897 High Similarity NPC142113
0.8889 High Similarity NPC197596
0.8859 High Similarity NPC291150
0.8851 High Similarity NPC470790
0.8851 High Similarity NPC472654
0.8851 High Similarity NPC470791
0.8851 High Similarity NPC470998
0.8836 High Similarity NPC34056
0.8808 High Similarity NPC141538
0.8808 High Similarity NPC155939
0.8808 High Similarity NPC296807
0.8808 High Similarity NPC469850
0.88 High Similarity NPC471002
0.8792 High Similarity NPC196864
0.8792 High Similarity NPC5180
0.8792 High Similarity NPC477404
0.8776 High Similarity NPC262198
0.8742 High Similarity NPC178932
0.8741 High Similarity NPC476943
0.8733 High Similarity NPC471000
0.8716 High Similarity NPC224418
0.8699 High Similarity NPC267632
0.8693 High Similarity NPC197137
0.8693 High Similarity NPC472283
0.8684 High Similarity NPC469336
0.8675 High Similarity NPC470996
0.8671 High Similarity NPC42400
0.8671 High Similarity NPC310830
0.8667 High Similarity NPC196846
0.8652 High Similarity NPC471006
0.8649 High Similarity NPC233763
0.8645 High Similarity NPC471003
0.8643 High Similarity NPC298190
0.8639 High Similarity NPC251865
0.8636 High Similarity NPC474932
0.863 High Similarity NPC121158
0.8618 High Similarity NPC471863
0.8611 High Similarity NPC236532
0.8611 High Similarity NPC220094
0.8601 High Similarity NPC146872
0.8582 High Similarity NPC471817
0.8581 High Similarity NPC56731
0.8571 High Similarity NPC167142
0.8571 High Similarity NPC470118
0.8553 High Similarity NPC308205
0.8553 High Similarity NPC29695
0.8553 High Similarity NPC472672
0.8553 High Similarity NPC182427
0.8553 High Similarity NPC322546
0.8543 High Similarity NPC46551
0.8542 High Similarity NPC310043
0.8542 High Similarity NPC470742
0.8526 High Similarity NPC471166
0.8526 High Similarity NPC471167
0.8526 High Similarity NPC470792
0.8523 High Similarity NPC346
0.8514 High Similarity NPC476944
0.8506 High Similarity NPC41880
0.8506 High Similarity NPC204663
0.8506 High Similarity NPC104736
0.85 High Similarity NPC198904
0.8497 Intermediate Similarity NPC253201
0.8497 Intermediate Similarity NPC302054
0.8497 Intermediate Similarity NPC30222
0.8478 Intermediate Similarity NPC179354
0.8477 Intermediate Similarity NPC329180
0.8472 Intermediate Similarity NPC214572
0.8467 Intermediate Similarity NPC221809
0.8467 Intermediate Similarity NPC71821
0.8462 Intermediate Similarity NPC191828
0.8457 Intermediate Similarity NPC167340
0.8452 Intermediate Similarity NPC195131
0.8452 Intermediate Similarity NPC472772
0.8452 Intermediate Similarity NPC304692
0.8447 Intermediate Similarity NPC469848
0.8446 Intermediate Similarity NPC223415
0.8446 Intermediate Similarity NPC80635
0.8442 Intermediate Similarity NPC35000
0.8442 Intermediate Similarity NPC264943
0.8435 Intermediate Similarity NPC20500
0.8431 Intermediate Similarity NPC469503
0.8431 Intermediate Similarity NPC75906
0.8421 Intermediate Similarity NPC476122
0.8418 Intermediate Similarity NPC469849
0.8417 Intermediate Similarity NPC74612
0.8414 Intermediate Similarity NPC307401
0.8411 Intermediate Similarity NPC93666
0.8408 Intermediate Similarity NPC69028
0.8408 Intermediate Similarity NPC329938
0.8403 Intermediate Similarity NPC92941
0.8397 Intermediate Similarity NPC475226
0.8387 Intermediate Similarity NPC175964
0.8387 Intermediate Similarity NPC471169
0.8387 Intermediate Similarity NPC60973
0.8387 Intermediate Similarity NPC209364
0.838 Intermediate Similarity NPC61788
0.8377 Intermediate Similarity NPC34421
0.8377 Intermediate Similarity NPC98206
0.8377 Intermediate Similarity NPC237259
0.8367 Intermediate Similarity NPC67003
0.8366 Intermediate Similarity NPC18135
0.8365 Intermediate Similarity NPC470875
0.8355 Intermediate Similarity NPC195325
0.8354 Intermediate Similarity NPC471168
0.8354 Intermediate Similarity NPC469338
0.8354 Intermediate Similarity NPC476197
0.8354 Intermediate Similarity NPC165218
0.8354 Intermediate Similarity NPC292389
0.8354 Intermediate Similarity NPC472669
0.8344 Intermediate Similarity NPC287559
0.8344 Intermediate Similarity NPC470941
0.8344 Intermediate Similarity NPC255414
0.8344 Intermediate Similarity NPC470789
0.8344 Intermediate Similarity NPC10088
0.8333 Intermediate Similarity NPC214495
0.8333 Intermediate Similarity NPC475066
0.8333 Intermediate Similarity NPC16922
0.8333 Intermediate Similarity NPC286722
0.8333 Intermediate Similarity NPC470119
0.8323 Intermediate Similarity NPC476262
0.8323 Intermediate Similarity NPC471175
0.8323 Intermediate Similarity NPC281258
0.8322 Intermediate Similarity NPC470741
0.8313 Intermediate Similarity NPC478179
0.8312 Intermediate Similarity NPC476201
0.8311 Intermediate Similarity NPC205765
0.8302 Intermediate Similarity NPC276551
0.8302 Intermediate Similarity NPC470940
0.8301 Intermediate Similarity NPC212257
0.8299 Intermediate Similarity NPC474722
0.8299 Intermediate Similarity NPC202260
0.8299 Intermediate Similarity NPC90953
0.8291 Intermediate Similarity NPC68848
0.8291 Intermediate Similarity NPC472767
0.8291 Intermediate Similarity NPC472668
0.8291 Intermediate Similarity NPC472771
0.8291 Intermediate Similarity NPC6326
0.8291 Intermediate Similarity NPC470939
0.8289 Intermediate Similarity NPC471007
0.828 Intermediate Similarity NPC237155
0.828 Intermediate Similarity NPC307383
0.828 Intermediate Similarity NPC473473
0.828 Intermediate Similarity NPC472671
0.828 Intermediate Similarity NPC475295
0.828 Intermediate Similarity NPC477403
0.8278 Intermediate Similarity NPC62799
0.8272 Intermediate Similarity NPC285227
0.8269 Intermediate Similarity NPC263265
0.8269 Intermediate Similarity NPC107646
0.8264 Intermediate Similarity NPC470740
0.8258 Intermediate Similarity NPC57998
0.8258 Intermediate Similarity NPC282445
0.8255 Intermediate Similarity NPC473152
0.825 Intermediate Similarity NPC478178
0.8239 Intermediate Similarity NPC285567
0.8239 Intermediate Similarity NPC472773
0.8239 Intermediate Similarity NPC477405
0.8239 Intermediate Similarity NPC283209
0.8239 Intermediate Similarity NPC419
0.8235 Intermediate Similarity NPC69647
0.8235 Intermediate Similarity NPC125182
0.8228 Intermediate Similarity NPC305016
0.8228 Intermediate Similarity NPC477402
0.8228 Intermediate Similarity NPC25255
0.8224 Intermediate Similarity NPC250228
0.8217 Intermediate Similarity NPC249021
0.8217 Intermediate Similarity NPC173544
0.8217 Intermediate Similarity NPC81405
0.821 Intermediate Similarity NPC470995
0.8205 Intermediate Similarity NPC44675
0.8205 Intermediate Similarity NPC214541
0.82 Intermediate Similarity NPC470273
0.82 Intermediate Similarity NPC243577
0.8199 Intermediate Similarity NPC472282
0.8199 Intermediate Similarity NPC473753
0.8199 Intermediate Similarity NPC473766
0.8199 Intermediate Similarity NPC476861

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471292 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8205 Intermediate Similarity NPD5761 Phase 2
0.8205 Intermediate Similarity NPD5760 Phase 2
0.7888 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD6764 Approved
0.7798 Intermediate Similarity NPD6765 Approved
0.7778 Intermediate Similarity NPD8434 Phase 2
0.7616 Intermediate Similarity NPD6785 Approved
0.7616 Intermediate Similarity NPD6784 Approved
0.7582 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD1471 Phase 3
0.7351 Intermediate Similarity NPD8032 Phase 2
0.7312 Intermediate Similarity NPD6273 Approved
0.7251 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD7236 Approved
0.7107 Intermediate Similarity NPD4628 Phase 3
0.7073 Intermediate Similarity NPD3226 Approved
0.7059 Intermediate Similarity NPD8127 Discontinued
0.7055 Intermediate Similarity NPD920 Approved
0.7025 Intermediate Similarity NPD2346 Discontinued
0.7018 Intermediate Similarity NPD6808 Phase 2
0.7006 Intermediate Similarity NPD2799 Discontinued
0.7006 Intermediate Similarity NPD7819 Suspended
0.7 Intermediate Similarity NPD1876 Approved
0.698 Remote Similarity NPD3972 Approved
0.697 Remote Similarity NPD7458 Discontinued
0.6954 Remote Similarity NPD3266 Approved
0.6954 Remote Similarity NPD3267 Approved
0.6933 Remote Similarity NPD642 Clinical (unspecified phase)
0.6918 Remote Similarity NPD2344 Approved
0.6909 Remote Similarity NPD7239 Suspended
0.6892 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6839 Remote Similarity NPD3268 Approved
0.6839 Remote Similarity NPD2313 Discontinued
0.6833 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6832 Phase 2
0.681 Remote Similarity NPD643 Clinical (unspecified phase)
0.6802 Remote Similarity NPD5494 Approved
0.6792 Remote Similarity NPD3748 Approved
0.679 Remote Similarity NPD7003 Approved
0.6766 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6765 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6752 Remote Similarity NPD2979 Phase 3
0.6752 Remote Similarity NPD4140 Approved
0.675 Remote Similarity NPD2796 Approved
0.6748 Remote Similarity NPD2309 Approved
0.6727 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6726 Remote Similarity NPD6599 Discontinued
0.6711 Remote Similarity NPD5327 Phase 3
0.6711 Remote Similarity NPD5585 Approved
0.6709 Remote Similarity NPD6355 Discontinued
0.6706 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6689 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6687 Remote Similarity NPD8166 Discontinued
0.6687 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7411 Suspended
0.6667 Remote Similarity NPD8404 Phase 2
0.6667 Remote Similarity NPD1247 Approved
0.6667 Remote Similarity NPD17 Approved
0.6647 Remote Similarity NPD6279 Approved
0.6647 Remote Similarity NPD6280 Approved
0.6647 Remote Similarity NPD919 Approved
0.6646 Remote Similarity NPD4307 Phase 2
0.6646 Remote Similarity NPD3887 Approved
0.6644 Remote Similarity NPD1241 Discontinued
0.6627 Remote Similarity NPD7028 Phase 2
0.6626 Remote Similarity NPD1243 Approved
0.6623 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6611 Remote Similarity NPD6559 Discontinued
0.6604 Remote Similarity NPD1899 Clinical (unspecified phase)
0.659 Remote Similarity NPD3749 Approved
0.659 Remote Similarity NPD7075 Discontinued
0.6585 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6585 Remote Similarity NPD3750 Approved
0.6585 Remote Similarity NPD4110 Phase 3
0.6582 Remote Similarity NPD6663 Approved
0.6581 Remote Similarity NPD2798 Approved
0.6579 Remote Similarity NPD1281 Approved
0.6573 Remote Similarity NPD7799 Discontinued
0.6554 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6552 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6543 Remote Similarity NPD2935 Discontinued
0.6543 Remote Similarity NPD2438 Suspended
0.6536 Remote Similarity NPD1608 Approved
0.6536 Remote Similarity NPD5844 Phase 1
0.6532 Remote Similarity NPD7057 Phase 3
0.6532 Remote Similarity NPD7058 Phase 2
0.6527 Remote Similarity NPD2532 Approved
0.6527 Remote Similarity NPD2534 Approved
0.6527 Remote Similarity NPD2533 Approved
0.6522 Remote Similarity NPD7097 Phase 1
0.6517 Remote Similarity NPD7473 Discontinued
0.6516 Remote Similarity NPD2797 Approved
0.6503 Remote Similarity NPD6004 Phase 3
0.6503 Remote Similarity NPD6005 Phase 3
0.6503 Remote Similarity NPD6002 Phase 3
0.6503 Remote Similarity NPD5763 Approved
0.6503 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6503 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6503 Remote Similarity NPD5762 Approved
0.65 Remote Similarity NPD4618 Approved
0.65 Remote Similarity NPD4622 Approved
0.6494 Remote Similarity NPD4359 Approved
0.6492 Remote Similarity NPD4107 Approved
0.649 Remote Similarity NPD5691 Approved
0.6481 Remote Similarity NPD4308 Phase 3
0.6478 Remote Similarity NPD7961 Discontinued
0.6467 Remote Similarity NPD6799 Approved
0.646 Remote Similarity NPD6353 Approved
0.6456 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6453 Remote Similarity NPD6801 Discontinued
0.6452 Remote Similarity NPD1283 Approved
0.645 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6448 Remote Similarity NPD8312 Approved
0.6448 Remote Similarity NPD8313 Approved
0.6442 Remote Similarity NPD6099 Approved
0.6442 Remote Similarity NPD2531 Phase 2
0.6442 Remote Similarity NPD6100 Approved
0.6441 Remote Similarity NPD7229 Phase 3
0.6437 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6437 Remote Similarity NPD7768 Phase 2
0.6433 Remote Similarity NPD5736 Approved
0.6429 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6424 Remote Similarity NPD2800 Approved
0.642 Remote Similarity NPD5688 Approved
0.642 Remote Similarity NPD5689 Approved
0.6416 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6415 Remote Similarity NPD6798 Discontinued
0.6415 Remote Similarity NPD3764 Approved
0.6415 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6414 Remote Similarity NPD2182 Approved
0.6404 Remote Similarity NPD3926 Phase 2
0.6402 Remote Similarity NPD2353 Approved
0.6402 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6398 Remote Similarity NPD5735 Approved
0.6395 Remote Similarity NPD5889 Approved
0.6395 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6395 Remote Similarity NPD5890 Approved
0.6384 Remote Similarity NPD7199 Phase 2
0.6383 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6382 Remote Similarity NPD1651 Approved
0.6379 Remote Similarity NPD3817 Phase 2
0.6375 Remote Similarity NPD4870 Approved
0.6373 Remote Similarity NPD4482 Phase 3
0.6369 Remote Similarity NPD1019 Discontinued
0.6369 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6364 Remote Similarity NPD1549 Phase 2
0.6364 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6354 Remote Similarity NPD8285 Discontinued
0.6352 Remote Similarity NPD7095 Approved
0.6348 Remote Similarity NPD6232 Discontinued
0.6343 Remote Similarity NPD4965 Approved
0.6343 Remote Similarity NPD4966 Approved
0.6343 Remote Similarity NPD4967 Phase 2
0.6341 Remote Similarity NPD1551 Phase 2
0.6341 Remote Similarity NPD4477 Approved
0.6341 Remote Similarity NPD4476 Approved
0.634 Remote Similarity NPD1778 Approved
0.6339 Remote Similarity NPD7685 Pre-registration
0.6335 Remote Similarity NPD3142 Approved
0.6335 Remote Similarity NPD3140 Approved
0.6313 Remote Similarity NPD7184 Clinical (unspecified phase)
0.631 Remote Similarity NPD7440 Discontinued
0.6308 Remote Similarity NPD7497 Discontinued
0.6306 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6303 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6303 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6301 Remote Similarity NPD6385 Approved
0.6301 Remote Similarity NPD6873 Phase 2
0.6301 Remote Similarity NPD6386 Approved
0.6299 Remote Similarity NPD3496 Discontinued
0.6298 Remote Similarity NPD3818 Discontinued
0.6298 Remote Similarity NPD7177 Discontinued
0.6296 Remote Similarity NPD1933 Approved
0.6292 Remote Similarity NPD6959 Discontinued
0.6286 Remote Similarity NPD5977 Approved
0.6286 Remote Similarity NPD5402 Approved
0.6286 Remote Similarity NPD2296 Approved
0.6286 Remote Similarity NPD5978 Approved
0.628 Remote Similarity NPD7033 Discontinued
0.6275 Remote Similarity NPD3025 Approved
0.6275 Remote Similarity NPD3024 Approved
0.6273 Remote Similarity NPD6233 Phase 2
0.6271 Remote Similarity NPD6234 Discontinued
0.6266 Remote Similarity NPD5647 Approved
0.6266 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6265 Remote Similarity NPD2897 Discontinued
0.6265 Remote Similarity NPD970 Clinical (unspecified phase)
0.6264 Remote Similarity NPD37 Approved
0.6264 Remote Similarity NPD6844 Discontinued
0.6264 Remote Similarity NPD1934 Approved
0.6258 Remote Similarity NPD6653 Approved
0.6258 Remote Similarity NPD1611 Approved
0.625 Remote Similarity NPD2354 Approved
0.625 Remote Similarity NPD3882 Suspended
0.6243 Remote Similarity NPD6585 Discontinued
0.6243 Remote Similarity NPD4380 Phase 2
0.6242 Remote Similarity NPD7094 Approved
0.6242 Remote Similarity NPD6858 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data